Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure. Experts say this large cohort study strengthens the case for using these GLP-1 ...

But now, a scientific study has revealed the surprising way that weight loss and type 2 diabetes drugs could be helping you out. Research suggested that the drugs could actually reduce the risk of heart patients being hospitalised or dying early by half.

A new experimental therapy helps restore the heart’s flexibility in models of stiffened heart failure. Michael Gotthardt and his colleagues at the Max Delbrück Center are working with U.S. researchers

The use of sacubitril/valsartan appears feasible and safe in recipients of left ventricular assist devices, reducing the need for blood pressure-lowering agents and improving quality of life.

GLP-1 drugs like Mounjaro, which were created to help type 2 diabetes patients and sometimes manage weight loss, actually have some other shock benefits

Most people who undergo chemotherapy do not develop heart failure. However, specific chemotherapy drugs may significantly increase your risk of heart failure and other cardiac problems. Chemotherapy is a powerful tool in the fight against cancer, but it ...